Literature DB >> 10797917

[Aids neurologic manifestations in childhood].

N T Rotta, C Silva, L Ohlweiler, I Lago, R Cabral, F Gonçalves, A M Almeida, R Khan, L Mello, J Ranzan, F Guedes.   

Abstract

INTRODUCTION: Children with AIDS get infected mainly by vertical transmission. DEVELOPMENT: That was what happened in 90% of the cases in a series of 340 HIV+ children followed at Hospital de Clínicas de Porto Alegre, Brazil. Currently, after the use of prophylactic treatment during pregnancy and the six first weeks of life, our transmission rate is 3% to 4%. The incidence of neurologic complications in the vertical transmission group was 49% in our prospective series, and due either to immunosuppression or primary neurological disease. Neurologic changes secondary to HIV constitute a complex syndrome, manifested by various degrees of cognitive, motor and behavioral delay. Encephalopathy can be either progressive or static. In our series, encephalopathy occurred in 32.5% of cases, developmental delay in 42.5%, seizures in 6%, speech delay in 5%, headaches in 2.5% and behavioral disorders in 2%. Central nervous system infections happened in 33.8% of our cases: acute bacterial infections in 11%, cytomegalovirus in 6.8%, toxoplasmosis in 5.9%, cryptococcal in 5%, tuberculous in 3.8% and syphilis in 1.3%. Hemorrhagic cerebrovascular accidents were seen in 2.5% of our cases, and peripheral neuropathy in 5%. Seventy percent of our cases had abnormalities in the CSF, 75% in brain CT scans and 45% in EEGs.
CONCLUSIONS: Treatment of children with AIDS and neurologic manifestations was based on specific drugs aimed at controlling viral replication. Best response was obtained with combined use of AZT and other anti-retroviral neuro-protective.

Entities:  

Mesh:

Year:  1999        PMID: 10797917

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  2 in total

1.  Late diagnosis of human immunodeficiency virus infection is linked to higher rates of epilepsy in children in the Eastern Cape of South Africa.

Authors:  Isabel A Michaelis; Maryke Nielsen; Craig Carty; Markus Wolff; Caroline A Sabin; John S Lambert
Journal:  South Afr J HIV Med       Date:  2020-06-30       Impact factor: 2.744

2.  Regression of attained milestones in an HIV infected infant.

Authors:  P Madhivanan; S N Mothi; N Kumarasamy; T Yepthomi; J Lambert; S Solomon
Journal:  Indian J Pediatr       Date:  2001-10       Impact factor: 5.319

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.